uridine triphosphate has been researched along with Polycystic Ovary Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campos-Contreras, ADR; Chávez-Genaro, R; De Ita-Pérez, DL; Díaz-Muñoz, M; Garay, E; González-Gallardo, A; Juárez-Mercado, AP; Vázquez-Cuevas, FG | 1 |
1 other study(ies) available for uridine triphosphate and Polycystic Ovary Syndrome
Article | Year |
---|---|
Experimental polycystic ovarian syndrome is associated with reduced expression and function of P2Y2 receptors in rat theca cells.
Topics: Animals; Cell Proliferation; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Female; Phosphorylation; Polycystic Ovary Syndrome; Promoter Regions, Genetic; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Signal Transduction; Testosterone; Theca Cells; Uridine Triphosphate | 2019 |